The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
Here's a roundup of top developments in the biotech space over the last 24 hours.
Stocks In Focus
Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase 2b/3 Study
What a Russian Invasion of Ukraine Would Mean for Markets as Biden Warns Putin of 'Severe Costs'
Investors on Friday got a taste of the sort of market shock that could come if Russia invades Ukraine.The spark came as Jake Sullivan, the White House national security adviser, warned Friday afternoo